Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lukas Angleitner-Boubenizek"'
Publikováno v:
Der Gynäkologe. 52:878-880
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2398ad4c5e286e4039c347a0c210ee26
https://doi.org/10.1007/s00129-019-04521-1
https://doi.org/10.1007/s00129-019-04521-1
Publikováno v:
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 40(1)
Desmoid tumour (DT), also known as aggressive fibromatosis, is a monoclonal proliferative disease with no metastatic potential that derives from mesenchymal progenitor cells (Penel et al. 2017). Th...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29308d19fe23fa68a4fc6204c9b633dc
https://pubmed.ncbi.nlm.nih.gov/31210068
https://pubmed.ncbi.nlm.nih.gov/31210068
Publikováno v:
Geburtshilfe und Frauenheilkunde.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d27d58a04ebb941dbb8a902905e413d3
https://doi.org/10.1055/s-0038-1671245
https://doi.org/10.1055/s-0038-1671245
Autor:
D Reimer, Lukas Angleitner-Boubenizek, W. Stummvoll, Radoslav Chekerov, Jalid Sehouli, Alexander Reinthaller, Toralf Reimer, Burkhard Brandt, Christian Marth
Publikováno v:
British Journal of Cancer
Background: This is the first study investigating the safety and efficacy of the trifunctional antibody catumaxomab administered i.p. at the end of cytoreductive surgery and postoperatively prior to standard chemotherapy in patients with primary epit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1db34e1e4cf1156554211eb823ef1b
https://doi.org/10.1038/bjc.2014.443
https://doi.org/10.1038/bjc.2014.443
Autor:
Paul Sevelda, Christian Schauer, Edgar Petru, M. Medl, Wolfgang Stummvoll, Lukas Angleitner-Boubenizek, Christian Marth, Alexander Reinthaller, Alain G. Zeimet, Wolfgang Dirschlmayer
Publikováno v:
Wiener klinische Wochenschrift. 122:649-652
The Calypso trial showed an improved progression-free survival with PEG-liposomal doxorubicin (PLD) and carboplatin (P) as compared with the standard regimen paclitaxel (PCLTX) and P in the second- or third-line treatment of platinum-sensitive epithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46867d28ce45aeedde9fbf3ac484b485
https://doi.org/10.1007/s00508-010-1483-1
https://doi.org/10.1007/s00508-010-1483-1
Autor:
Lothar Schiller, Michael Rohde, Marianne Bernhart, Lukas Angleitner-Boubenizek, Ursula Pluschnigg, Jana Polachova, Tamara Hernler, Otto Gehmacher, August Zabernigg, Angelika Lanz-Veit, Wolfgang Stangl, Rene Schramböck, Kerstin Busch, Günther G. Steger, Uwe Kastner, Johannes Andel, Ralf Thödtmann, Edgar Petru
Publikováno v:
Wiener Medizinische Wochenschrift. 158:169-173
BACKGROUND: Palonosetron is a new generation 5-HT3-receptor antagonist with a significantly prolonged half-life and a once-a-day administration compared to the conventional setrons. To evaluate the antiemetic efficacy of palonosetron in the daily hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055f70741e09be80fa2dd67449f732b3
https://doi.org/10.1007/s10354-008-0515-1
https://doi.org/10.1007/s10354-008-0515-1
Autor:
Michael Seifert, Lukas Angleitner-Boubenizek, Paul Speiser, Edgar Petru, Paul Sevelda, Christoph Benedicic, Alain G. Zeimet, Wolfgang Stummvoll, Christian F. Singer, Alexander Reinthaller, Michael Hubalek
Publikováno v:
Wiener klinische Wochenschrift. 124(11-12)
The current knowledge and recommendations on the clinical use of granulocyte colony-stimulating factors (G-CSF) in gynecologic cancers including breast cancer, along with the clinical experience of the members of the working group of the Austrian Arb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d803eda2181d3562901f1bcb5114fd0
https://pubmed.ncbi.nlm.nih.gov/22739650
https://pubmed.ncbi.nlm.nih.gov/22739650
Autor:
Birgit, Volgger, Edgar, Petru, Lukas, Angleitner-Boubenizek, Monika, Weigert, Alexander, Reinthaller, Harald, Lass, Anita, Stempfl, Christian, Gamper, Martina, Deibl, Christian, Marth
Publikováno v:
Anticancer research. 28(6B)
The influence of two regimens of erythropoetin beta on haemoglobin level, quality of life (QoL) and side-effects in patients with gynaecological malignancies was assessed.A total of 119 patients during chemotherapy were randomised to either standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf724bc61efde1e9688dc23b4e135d95
https://pubmed.ncbi.nlm.nih.gov/19192659
https://pubmed.ncbi.nlm.nih.gov/19192659
Autor:
Lothar C. Fuith, G Bogner, Michael Rohde, Alain G. Zeimet, Gudrun Windbichler, Dietmar Fuchs, Birgit Volgger, Lukas Angleitner-Boubenizek, Ursula Denison, Christian Marth, Anton Graf, Gerhard Sliutz
Publikováno v:
Journal of Clinical Oncology. 32:5561-5561
5561 Background: Neopterin is produced by activated macrophages upon stimulation with interferon-gamma (IFN-g) and thus elevated concentrations in patients indicate cellular immune response. Most s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a4309ff6f684e8b1d701721550d503
https://doi.org/10.1200/jco.2014.32.15_suppl.5561
https://doi.org/10.1200/jco.2014.32.15_suppl.5561
Autor:
Martin Imhof, Markus Lipovac, Astrid Hrdina, István Láng, Heike Rottmann, Johannes Barta, Ivan Gomez, Lukas Angleitner-Boubenizek, Judith Lafleur, Marianne Imhof, Ewa Krupa, Katharin Pieta
Publikováno v:
Journal of Clinical Oncology. 31:3052-3052
3052 Background: Prognosis of ovarian cancer remains poor after initial responsiveness to surgery and chemotherapy followed by high recurrence and mortality rates and new experimental approaches are warranted. Our goal was to evaluate a novel DC-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5592ebe497954e942b53cc8a27b1e34b
https://doi.org/10.1200/jco.2013.31.15_suppl.3052
https://doi.org/10.1200/jco.2013.31.15_suppl.3052